Delivery Order SPE2DB24D3013-SPE2DB25FFQBW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,940.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed price, non-set-aside contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger Indefinite Delivery Contract vehicle with DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) with a ceiling value of $1,473.61. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $1,199.46. This firm fixed-price delivery order, which is set to be completed by July 30, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,475.22 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Dextroamphetamine-Amphetamine 25 mg capsules (100-count). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a routine pharmaceutical procurement to support federal medical supply needs. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's...
- The Defense Logistics Agency awarded a $1,953.40 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100 count). This firm fixed price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $2,030.22. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a $5,025.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units). The contract, which is classified as a child delivery order with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.71 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQBWDelivery Order
The Defense Logistics Agency awarded a $1,507.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This non-set-aside contract is set to be completed by September 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026 that serves as the company's comprehensive global pharmaceutical support vehicle for the U.S. military healthcare system. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains through competitively awarded agreements with the Defense Logistics Agency. This particular order represents a routine delivery of controlled pharmaceutical products to support military medical supply chain requirements, consistent with the company's ongoing role as a primary pharmaceutical vendor for the Department of Defense and affiliated healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/3/25 |